📈 Access Engineering Invests US$ 6.9 Mn in Medical Infrastructure

Access Engineering PLC has launched a cyclotron-based radiopharmaceutical production facility, marking a strategic diversification into the healthcare infrastructure sector. • Investment Details: Total investment of nearly US$ 6.9 million under a Build, Own, and Operate (BOO) model. Access Engineering holds a 60% stake in the project via Access Medical Tracers Ltd. • Core Purpose: The facility will produce short-lived radioactive isotopes for PET scans and cancer diagnostics. Local production is critical for timely hospital availability due to the short half-life of these isotopes. • Sector Diversification: Move signals a shift beyond core engineering & construction into high-tech medical manufacturing. • Financial Performance: • Group revenue grew 38% YoY to Rs. 36 Bn (9 months ending Dec 2025). • After-tax profits rose 15% to Rs. 4 Bn. • Revenue breakdown: Automobile (Rs. 17 Bn), Civil Engineering (Rs. 13 Bn), and Construction Materials (Rs. 5.7 Bn). • Share price closed at Rs. 72.50 with net assets per share at Rs. 37.61. The facility is scheduled for commissioning today (Feb 16, 2026).